AQUESTIVE THERAPEUTICS INC's ticker is AQST and the CUSIP is 03843E104. A total of 50 filers reported holding AQUESTIVE THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11 | -100.0% | 7,144 | -71.2% | 0.00% | – |
| Q1 2022 | $65,000 | -66.5% | 24,829 | -50.0% | 0.00% | – |
| Q4 2021 | $194,000 | +59.0% | 49,658 | +77.8% | 0.00% | – |
| Q3 2021 | $122,000 | -2.4% | 27,926 | -11.0% | 0.00% | – |
| Q2 2021 | $125,000 | +45.3% | 31,382 | +88.9% | 0.00% | – |
| Q1 2021 | $86,000 | +152.9% | 16,612 | +159.0% | 0.00% | – |
| Q4 2020 | $34,000 | -20.9% | 6,415 | -29.4% | 0.00% | – |
| Q3 2020 | $43,000 | -72.4% | 9,080 | -71.9% | 0.00% | – |
| Q2 2020 | $156,000 | +15500.0% | 32,342 | +20240.9% | 0.00% | – |
| Q4 2019 | $1,000 | -50.0% | 159 | -80.4% | 0.00% | – |
| Q3 2019 | $2,000 | 0.0% | 811 | +93.1% | 0.00% | – |
| Q2 2019 | $2,000 | -95.0% | 420 | -92.8% | 0.00% | – |
| Q1 2019 | $40,000 | +17.6% | 5,861 | +199.6% | 0.00% | – |
| Q3 2018 | $34,000 | – | 1,956 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bratton Capital Management, L.P. | 9,810,958 | $11,479,000 | 100.00% |
| Vahanian & Associates Financial Planning Inc. | 695,258 | $813,000 | 2.80% |
| Latash Investments, LLC | 243,134 | $284,000 | 0.23% |
| Bracebridge Capital, LLC | 428,571 | $501,000 | 0.09% |
| Running Point Capital Advisors, LLC | 10,000 | $12,000 | 0.01% |
| D.B. Root & Company, LLC | 12,500 | $14,000 | 0.01% |
| Schonfeld Strategic Advisors LLC | 406,700 | $475,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 142,956 | $167,000 | 0.00% |
| IFP Advisors, Inc | 6,500 | $104,000 | 0.00% |
| Financial Advocates Investment Management | 27,000 | $32,000 | 0.00% |